Results 121 to 130 of about 1,250,387 (316)
Aging and Cancer, EarlyView.This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha +4 more
wiley +1 more source
Algorithms: How they can reduce competition and harm consumers (2021) [PDF]
, 2022 Competition and Markets Authority
core
Unleashing Competition in EU Business Services. CEPS Policy Brief No. 284, 24 September 2012 [PDF]
, 2012 In most EU member states, the business services industry has booked no productivity growth during the last two decades. The industry’s performance in the other member states was weaker than that of its US counterparts.
Kox, Henk
core
Aging and Cancer, EarlyView.ABSTRACT As global populations age, cancer is increasingly becoming a leading cause of morbidity and mortality among older adults, particularly in low‐ and middle‐income countries (LMICs). Despite accounting for the majority of new cancer cases and deaths, older individuals remain underrepresented in cancer research, clinical guidelines, and health ...
Ibrahim Bidemi Abdullateef +2 more
wiley +1 more source
ACCC telecommunications report 2014-15
, 2016 A consumer market hungry for data is driving competition and leading to better service offerings for Australians, according to two new reports. Prepared annually by the Australian Competition and Consumer Commission (ACCC), the reports provide a
Australian Competition and Consumer Commission
core
Aging Is a Key Driver for Adult Acute Myeloid Leukemia
Aging and Cancer, EarlyView.Acute myeloid leukemia (AML) is a classical age‐related hematologic malignancy, and a key driver of AML is aging, which profoundly regulates intrinsic factors such as genomic instability, epigenetic reprogramming, and metabolic dysregulation, and alters bone marrow microenvironment.
Rong Yin, Haojian Zhang
wiley +1 more source
, 2020 Leniency in EU Competition Law' provides a comprehensive analysis of the leniency procedure in the European Union (EU) cartel enforcement. Applications for lenient treatment by whistleblowers are an essential feature of cartel enforcement.
Halvorsen Barlund Ingrid Margrethe
core
Mutant NPM1 in Acute Myeloid Leukemia Initiation and Maintenance
Aging and Cancer, EarlyView.NPM1 mutations drive acute myeloid leukemia by acting as neomorphic transcriptional regulators that cooperate with Menin–MLL and XPO1 to sustain HOX/MEIS1 expression and block differentiation. Targeting these mutant‐specific transcriptional dependencies provides a rational therapeutic strategy for NPM1‐mutated AML.
Yanan Jiang +3 more
wiley +1 more source
Free Speech is Incomplete? Big Tech in a Distant Mirror
Yearbook of Antitrust and Regulatory StudiesIn 1961, Alexander Meiklejohn claimed that the First Amendment, the US provision guaranteeing free speech, is an absolute. Echoing this in the context of the rise of fake news, Tim Wu has recently asked whether the First Amendment might have become ...
Jan Polański
doaj +1 more source
Optimal substantive standards for competition authorities
, 2016 Initial research was funded by an ESRC grant RES-052-23-221I “Optimal Enforcement and Decision Structures for Competition Policy” and subsequently it has been co-financed by the European Union (European Social Fund – ESF) and Greek National funds through
Ulph, David Tregear +2 more
core +1 more source